title: RelA/NF-kappaB recruitment on the bax gene promoter antagonizes p73-dependent apoptosis in costimulated T cells.
abstract: The balance between antiapoptotic and proapoptotic proteins of the Bcl-2 family is critical in determining the fate of T cells in response to death stimuli. Proapoptotic genes, such as bax, are generally regulated by the p53 family of transcription factors, whereas NF-kappaB subunits can activate the transcription of antiapoptotic Bcl-2 members. Here, we show that CD28 activation protects memory T cells from irradiation-induced apoptosis by both upregulating bcl-xL and inhibiting bax gene expression. We found that p73, but not p53, binds to and trans-activates the bax gene promoter in irradiated T cells. The activation of RelA/NF-kappaB subunit in CD28 costimulated T cells and its binding onto the bax gene promoter results in suppression of bax transcription and decrease in both p73 and RNA polymerase II recruitment in vivo. RelA recruitment on the bax gene promoter is also accompanied by the lost of p300 binding and the parallel appearance of histone deacetylase-1-containing complexes. These findings identify RelA/NF-kappaB as a critical regulator of T-cell survival by affecting the balance of Bcl-2 family members.
authors.affiliation: Department of Cellular and Developmental Biology, University La Sapienza, Via dei Sardi 70, 00185 Rome, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Cianfrocca
authors.forename: M
authors.initials: M
authors.lastname: Muscolini
authors.forename: V
authors.initials: V
authors.lastname: Marzano
authors.forename: A
authors.initials: A
authors.lastname: Annibaldi
authors.forename: B
authors.initials: B
authors.lastname: Marinari
authors.forename: M
authors.initials: M
authors.lastname: Levrero
authors.forename: A
authors.initials: A
authors.lastname: Costanzo
authors.forename: L
authors.initials: L
authors.lastname: Tuosto
mesh_terms: D017209:Apoptosis / Q000528:radiation effects; D018106:CD28 Antigens / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000502:physiology* / Q000528:radiation effects; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D004268:DNA-Binding Proteins / Q000378:metabolism*; D006801:Humans; D007156:Immunologic Memory; D019169:Jurkat Cells; D009687:Nuclear Proteins / Q000378:metabolism*; D011401:Promoter Regions, Genetic; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D012319:RNA Polymerase II / Q000378:metabolism; D013601:T-Lymphocytes / Q000502:physiology* / Q000528:radiation effects; D051996:Transcription Factor RelA / Q000378:metabolism*; D000072160:Tumor Protein p73; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism; D025521:Tumor Suppressor Proteins / Q000378:metabolism*; D051028:bcl-2-Associated X Protein / Q000235:genetics* / Q000378:metabolism; D051020:bcl-X Protein / Q000235:genetics / Q000378:metabolism
chemical_list: D018106:CD28 Antigens; D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; C000606460:TP73 protein, human; D051996:Transcription Factor RelA; D000072160:Tumor Protein p73; D016159:Tumor Suppressor Protein p53; D025521:Tumor Suppressor Proteins; D051028:bcl-2-Associated X Protein; D051020:bcl-X Protein; D051057:Proto-Oncogene Proteins c-akt; D012319:RNA Polymerase II